Technetium(v) and rhenium(v) complexes for 5-HT2A serotonin receptor binding: Structure-affinity considerations

Andersen, 1994, Development of a receptor-interaction model for serotonin 5-HT2 receptor antagonists: Predicting selectivity with respect to dopamine D2 receptors, J. Med Chem., 37, 950, 10.1021/jm00033a013

Baidoo, 1995, Serotonin-1A receptor binding technetium-99m-labelled complexes, J. Nucl. Med., 36, 28P

Baron, 1985, Pharmacological studies in man with PET: An investigation using 11C-labelled ketanserin, a 5HT2 receptors antagonist, J. Cereb. Blood Flow Metab., 5, 471, 10.1007/978-3-642-70054-5_70

Berridge, 1983, 11C-Labelled ketanserin: A selective serotonin S2 antagonist, J. Lab. Compd. Radiopharm., 20, 73, 10.1002/jlcr.2580200110

Chi, 1994, Homodimeric and heterodimeric bis(amino thiol) oxometal complexes with rhenium(V) and technetium (V): Control of heterodimeric complex formation and an approach to metal complexes that mimic steroid hormones, J. Med. Chem., 37, 928, 10.1021/jm00033a010

Crouzel, 1988, Labelling of a serotonergic ligand with 18F: [18F]setoperone, J. Lab. Compd. Radiopharm., 25, 403, 10.1002/jlcr.2580250407

Crouzel, 1992, Ligands and tracers for PET studies of the 5-HT system—current status, Nucl. Med. Biol., 19, 857

Del, 1994, Synthesis and in vivo evaluation of a 99m/99Tc-DADT-benzovesamicol: A potential marker for cholinergic neurons, Nucl. Med. Biol., 21, 197, 10.1016/0969-8051(94)90009-4

Eckelman, 1995, Radiolabeling with technetium-99m to study high-capacity and low-capacity biochemical systems, Eur. J. Nucl. Med., 22, 249, 10.1007/BF01081522

Edvardsen, 1992, Molecular dynamics of serotonin and ritanserin interacting with the 5-HT2 receptor, Mol. Brain Res., 14, 166, 10.1016/0169-328X(92)90171-7

Eison, 1994, Serotonergic mechanisms in anxiety, Prog. Neuropsychopharmacol. Biol. Psychiatry, 18, 47, 10.1016/0278-5846(94)90023-X

Fietz, 1995, Synthesis and crystal structure of (3-thiapentane-1.5-dithiolato)chlorooxorhenium(V), Inorg. Chim. Acta, 231, 233, 10.1016/0020-1693(94)04351-U

1990, Vol 6

Herndon, 1992, Ketanserin analogues: Structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding, J. Med. Chem., 35, 4903, 10.1021/jm00104a017

Johannsen, 1978, meso- und rac.-2,3-Dimercaptosuccinatotechnetat(V), Radiochem. Radioanal. Lett., 36, 111

Johannsen, 1995, Oxotechnetium(V) and oxorhenium(V) complexes as potential imaging agents for the serotonin receptor, J. Nucl. Med., 36, 27P

Jurisson, 1995, Boronic acid adducts of technetium dioxime (BATO) complexes derived from quinuclidine benzilate (QNB) boronic acid stereoisomers: Syntheses and studies of their binding to the muscarinic acetylcholine receptor, Nucl. Biol. Med., 22, 269, 10.1016/0969-8051(94)00125-4

Kristiansen, 1993, Molecular modelling of ketanserin and its interactions with the 5-HT2 receptor, Med. Chem. Res., 3, 370

Kung, 1995, New TcO(III) and ReO(III) N2S2 complexes as potential CNS 5-HT1A receptor imaging agents, 293

Kusumi, 1994, Serotonin-induced platelet intracellular calcium mobilization in depressed patients, Psychopharmacology, 113, 322, 10.1007/BF02245204

Lemaire, 1991, [18F]Altanserin, a potential radioligand for the study of serotonin receptors: Radiolabeling and in vivo biological behaviour in rats, J. Nucl. Med., 32, 2266

Lever, 1989, The status and future of technetium-99m radiopharmaceuticals, 649

Lever, 1994, Novel technetium ligands with affinity for the muscarinic cholinergic receptor, Nucl. Med. Biol., 21, 157, 10.1016/0969-8051(94)90004-3

Lowry, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6

McBride, 1994, The relationship of platelet 5-HT2 receptor indices to major depressive disorder, personality traits, and suicidal behavior, Biol. Psychiatry, 35, 295, 10.1016/0006-3223(94)90033-7

McKenna, 1989, Common receptors for hallucinogens in rat brain: A comparative autoradiographic study using [125I]LSD and [125I]DOI, a new psychomimetic radioligand, Brain Res., 476, 45, 10.1016/0006-8993(89)91535-7

Mertens, 1989, High selective serotonin S2 receptor mapping with SPECT in baboon brain, J. Nucl. Med., 30, 741

Minick, 1988, A comprehensive method for determining hydrophobicity constants by reversed-phase high performance liquid chromatography, J. Med. Chem., 31, 1923, 10.1021/jm00118a010

Ohuoha, 1993, The role of serotonin in schizophrenia: An overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system, Psychopharmacology, 112, S5, 10.1007/BF02245003

Pietzsch, 1989, Lipophilic technetium complexes VI: Neutral oxotechnetium(V) complexes with monothiole/tridentate dithiole coordination, Inorg. Chim. Acta, 165, 163, 10.1016/S0020-1693(00)83233-8

Reynolds, 1984, Reduced binding of [3H]ketanserin to cortical 5-HT2 receptor in senile dementia of the Alzheimer type, Neurosci. Lett., 44, 47, 10.1016/0304-3940(84)90219-2

Samnick, 1995, Synthesis, characterization and biodistribution of neutral and lipid-soluble 99mTc-BP-BAT and 99mTc-BUP-BAT: Possible ligands for dopamine receptor imaging with SPECT, 293

Scheffel, 1988, Comparison of technetium-99m amino-alkyl diaminodithiol (DADT) analogs as potential brain blood flow imaging agents, J. Nucl. Med., 29, 73

Scheunemann M., Pietzsch H.-J., Spies H., Fietz T., Leibnitz P., Brust P., J. Wober and B. Johannsen (1996) Submitted for publication.

Schotte, 1989, Identification of 5-HT2 receptors, α-adrenoreceptors and amine release sites in rat brain by autoradiography with [125I]7-amino-8-iodo-ketanserin, Eur. J. Pharmacol. [Mol. Sect.], 172, 99, 10.1016/0922-4106(89)90001-1

Spies, 1994, Trigonal-bipyramidal technetium and rhenium complexes with tetradentate tripodal NS3 ligands, Angew. Chem. Intern. Ed. Engl., 33, 1354, 10.1002/anie.199413541

Spies, 1995, The “n+1” Concept in the Synthesis Strategy of Novel Technetium and Rhenium Tracers, 293

Spies, 1995, Alkyl and aryl substituted oxorhenium(V) complexes with tridentate/monodentate coordination, J. Chem. Soc. Dalton Trans., 2277, 10.1039/dt9950002277

Spies, 1995, Functionalization of technetium complexes to make them active in vivo, Analyst, 120, 775, 10.1039/an9952000775